Anagenics Limited (ASX:AN1) Completes Haircare IP Sale and Enters Earn-Out Arrangement with York St Brands

Sonal Goyal

05 November 2026 03:56 PM AEDT

Anagenics Limited (ASX:AN1) Completes Haircare IP Sale and Enters Earn-Out Arrangement with York St Brands

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Anagenics has completed the unconditional sale of its haircare technology and associated intellectual property, including the évolis Brand assets, to YSB IP Pty Ltd, part of York St Brands.
The transaction delivers an upfront cash payment on completion, with ongoing quarterly payments tied to net sales of products utilising the transferred intellectual property over up to eight years.
The deal builds on a prior licence arrangement entered in July 2024, through which York St Brands created the Bouf brand, and crystallises the commercial value developed since that agreement.
Anagenics plans to continue assessing complementary growth opportunities through BLC Cosmetics and is in active discussions regarding its remaining non-haircare intellectual property assets.

Anagenics Limited (ASX:AN1), an ASX-listed health, beauty, and wellness company, announced on 5 November 2026 that it had completed an unconditional asset sale with YSB IP Pty Ltd, a Subsidiary of York St Brands, covering its haircare technology and associated intellectual property. The Assets transferred include the évolis brand, which Anagenics had previously licensed to York St Brands in July 2024, enabling the creation of the Bouf haircare brand. The transaction marks a deliberate step in simplifying the company's portfolio and creating financial capacity ahead of what it describes as its next phase of strategic evolution. Anagenics is a wholly Australian-listed entity that operates primarily through its subsidiary BLC Cosmetics Pty Ltd.

Transaction Structure and Commercial Terms

The agreement provides Anagenics with an upfront cash amount on completion, alongside an additional sum representing outstanding royalties accumulated under the prior licence arrangement for the current quarter. The forward-looking element of the deal consists of quarterly earn-out payments calculated as a percentage of the net sales of products that incorporate the transferred intellectual property. These ongoing payments are subject to an annual contractual minimum and are structured over a period of up to eight years, providing Anagenics with a degree of income predictability tied to Bouf's commercial performance without requiring further direct Investment in the haircare segment.

The agreement also includes a cap on the total future earn-out payments and contains early payout provisions applicable in certain defined circumstances, using a discounted calculation of the remaining cap balance. Anagenics highlighted that if recent sales trends are maintained, the total aggregate value arising from its arrangements with York St Brands, including prior licence fees, the completion payment, and projected future earn-out receipts, could be meaningful relative to the company's current portfolio scale. However, the company acknowledged that reaching such aggregate values depends on future sales performance and the specific terms of the agreement and cannot be treated as a guaranteed outcome.

Strategic Rationale and Portfolio Direction

Anagenics framed the transaction as an extension of its Partnership with York St Brands rather than a complete separation. By divesting the Sale IP, Anagenics enables YSB to deploy its own sales and Marketing capabilities to extract further value from the acquired technology, while Anagenics retains ongoing financial participation through the earn-out structure without being directly responsible for funding the commercialisation effort. The company noted that the transaction crystallises the value of the Capital invested by shareholders and the work undertaken over many years by the company and its staff in developing the haircare technology.

The deal follows a period of financial improvement for Anagenics. The company reported a maiden full-year net profit after tax for the year ended 30 June 2026, reversing a loss recorded in the prior financial year. The completion payment is expected to further improve the Balance Sheet and provide additional financial and strategic flexibility. Anagenics indicated that it will continue to assess opportunities through BLC Cosmetics, its Wholly Owned Subsidiary focused on the sales and distribution of leading Australian and international cosmetic and wellness brands, and that it is separately in active discussions to monetise non-haircare intellectual property assets remaining in the portfolio.

Key Takeaways

The IP sale to York St Brands reflects Anagenics' broader intent to streamline its asset base and redirect capital towards areas it considers higher priority. By converting a licensing relationship into a completed asset sale with an ongoing earn-out structure, the company retains exposure to future Revenue from Bouf's growth while removing the operational responsibility for the haircare segment. The transaction complements the company's return to profitability in its most recent financial year and positions it with a strengthened balance sheet from which to evaluate further opportunities within the health, beauty, and wellness sector through BLC Cosmetics. Investors will likely watch how the earn-out payments perform relative to the contractual minimums and what direction management takes with the remaining non-haircare intellectual property discussions currently underway.

FAQs

Q: What did Anagenics sell and to whom?

A: Anagenics sold its haircare technology and associated intellectual property, including the évolis brand assets, to YSB IP Pty Ltd, which is part of York St Brands. The transaction was completed unconditionally on 5 November 2026.

Q: What is the earn-out arrangement?

A: Under the earn-out arrangement, Anagenics will receive quarterly payments equal to a percentage of net sales of products using the sold intellectual property for up to eight years, subject to annual contractual minimum payments and an overall cap on future earnings.

Q: How does this deal relate to the Bouf brand?

A: York St Brands created the Bouf haircare brand using technology it had previously licensed from Anagenics in July 2024. The asset sale formalises the transfer of the underlying intellectual property that underpins Bouf's products, with Anagenics now participating in future Bouf sales through the earn-out rather than a licensing arrangement.

Q: What will Anagenics focus on going forward?

A: Anagenics plans to focus on its BLC Cosmetics subsidiary, which distributes leading Australian and international cosmetic and wellness brands, while also evaluating opportunities to monetise its non-haircare intellectual property and exploring complementary growth avenues.

Q: Does this transaction guarantee Anagenics a fixed future income?

A: The arrangement includes annual contractual minimum earn-out payments, providing a base level of income, but the actual future payments depend on sales performance of York St Brands' products using the transferred intellectual property. The agreement has a cap on total future earn-out payments and includes early payout provisions under certain conditions.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.